Dr. Chen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Center Dr
Bethesda, MD 20892Phone+1 301-496-1196
Education & Training
Baylor College of MedicineFellowship, Hematology and Medical Oncology, 1989 - 1991
University of Texas Southwestern Medical Center/St Paul Medical CenterResidency, Internal Medicine, 1987 - 1989
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineInternship, Internal Medicine, 1986 - 1987
University of Tennessee Health Science Center College of MedicineClass of 1986
Certifications & Licensure
FL State Medical License 1997 - 2026
TX State Medical License 1988 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Plasma ctDNA as a Treatment Response Biomarker in Metastatic Cancers: Evaluation by the RECIST Working Group.Alexander W Wyatt, Saskia Litiere, Francois-Clément Bidard, Luc Cabel, Lars Dyrskjøt
Clinical Cancer Research. 2024-11-15 - 1 citationsDiagnostic performance of [Ga]DOTATATE PET/CT, [F]FDG PET/CT, MRI of the spine, and whole-body diagnostic CT and MRI in the detection of spinal bone metastases associa...Abhishek Jha, Mayank Patel, Alexander Ling, Ritu Shah, Clara C Chen
European Radiology. 2024-10-01 - 1 citationsPhase II Trial of Afatinib in Patients With-Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A.Scott N Gettinger, Zihe Song, Karen L Reckamp, Jeffrey A Moscow, Robert J Gray
JCO Precision Oncology. 2024-07-01
Journal Articles
- Effect of Capivasertib in Patients with an AKT1 E17K-Mutated TumorKevin Kalinsky, Edith P Mitchell, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Alice P Chen, Keith T Flaherty, JAMA Oncology
Authored Content
- Phase II Trial of Veliparib in Patients with Previously Treated BRCA-Mutated Pancreas Ductal Adenocarcinoma☆January 2018
- Phase II Trial of Veliparib in Patients with Previously Treated BRCA-Mutated Pancreas Ductal Adenocarcinoma☆January 2018
- Phase II Trial of Veliparib in Patients with Previously Treated BRCA-Mutated Pancreas Ductal Adenocarcinoma☆January 2018
Press Mentions
Drug Approved to Help Young Patients Battle a Rare CancerJanuary 2nd, 2023- Slips, Slides: Winter Injuries Can Be SeriousJanuary 2nd, 2023
NIH Clinical Trials Apply Genomics to Chronic Disease ManagementJune 6th, 2019- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
